{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-101952","form_type":"8-K","ticker":"CTSO","cik":"0001175151","company_name":"Cytosorbents Corp","filed_at":"2023-09-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.312603+00:00","generated_at":"2026-06-10T13:03:40.297174+00:00","sec_items":["1.01","5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"CytoSorbents appoints Kathleen P. Bloch as full-time CFO with new employment agreement","bullets":["Bloch returns as CFO effective Sept 2, 2023, replacing former CFO D'Amico after his departure following an investigation.","Annual base salary of $425,000; eligible for cash bonus up to 45% of base salary at CEO's discretion.","Equity award: 45,000 RSUs (25k vest immediately, 10k on each of first two anniversaries) and 30,000 options (same vesting schedule).","Employment agreement runs through Dec 31, 2025 unless terminated earlier."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-101952","json":"https://secwatch.observer/filing/0001104659-23-101952.json","markdown":"https://secwatch.observer/filing/0001104659-23-101952.md","text":"https://secwatch.observer/filing/0001104659-23-101952.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1175151/000110465923101952/0001104659-23-101952-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1175151/000110465923101952/tm2326325d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T13:03:40.297174+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0ac0f57608","claim":"Kathleen P. Bloch was appointed as Chief Financial Officer at Cytosorbents Corp.","evidence_excerpt":"Ms. Bloch will continue to serve as the Company’s Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1175151/000110465923101952/0001104659-23-101952-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}